The life settlement market, like many other alternative assets, has had to navigate its fair share of challenges in the past few years. Greg Winterton caught up with Ryan McTernan, Senior Managing Director at Fifth Season Investments, to get his take on the state of the space as we begin 2025.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
New Report Provides Both Food for Thought and Positive Reinforcement for Life Settlement Market
The life settlement industry regularly touts the lack of correlation to public equity and liquid…
UK Pension Risk Transfer Market Posts Another Stellar Year
The UK’s pension risk transfer (PRT) market had a busy year in 2024, continuing the…
Activity in Asset Intensive Life Reinsurance Solutions to Remain Healthy
The higher interest rate environment of the past few years has had the impact of…
Advancing Frontiers in Metastatic Melanoma: Innovations, Treatments, and Improved Survival Outcomes
Melanoma of the skin (cutaneous melanoma) is a malignant tumor originating from melanocytes, the skin…
